Feedstuffs is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CIDRAP tackles antimicrobial resistance

Project will provide current, free, accurate and comprehensive information and educational resources on antimicrobial stewardship.

The University of Minnesota’s Center for Infectious Disease Research & Policy (CIDRAP) is tackling antimicrobial resistance, one of the world’s biggest public health issues, through a new program called the Antimicrobial Stewardship Project (ASP).

The project will help address this issue by providing current, free, accurate and comprehensive information and educational resources on antimicrobial stewardship practice, research and policy.

Antimicrobial stewardship refers to efforts to improve the appropriate use of antimicrobials by promoting the selection of optimal antimicrobial drug regimen, dose, duration of therapy and route of administration. The overuse and misuse of antimicrobials in people and animals contribute to the increased occurrence of disease-causing microbes developing resistance and subsequently reducing the effectiveness of antibiotics in treating infectious diseases.

“CIDRAP is offering our knowledge and expertise in antimicrobial resistance to help provide possible solutions to this growing global public health problem,” said Dr. Michael Osterholm, University of Minnesota regents professor and CIDRAP director. “We’ve assembled a panel of 13 internationally renowned advisory experts to work with us. These people have expertise in a wide range of areas, including antimicrobial stewardship, antimicrobial resistance, clinical and veterinary medicine, clinical pharmacology and public health.”

Antimicrobial stewardship must be addressed globally versus on a country-by-country basis because the problem of resistance is found on every continent and transcends political boundaries, CIDRAP explained. The ASP initiative intends to promote global collaboration through engagement of international experts and through working closely with other international programs devoted to addressing the problems of antimicrobial resistance.

The development of ASP will assemble multiple initiatives to bring together the most current information available to create a “one-stop shop” website. The new ASP website will feature:

* Expert webinars and podcasts;

* ASP news and information;

* Online resources available from the U.S. and other countries;

* An online journal club;

* Policy updates;

* Bibliographies and online resources;

* An events calendar and conference summaries, and

* Social media outreach.

CIDRAP’s new website will continue to report from a news perspective and will provide the most comprehensive news and information both existing and new, along with original content.

“The best science in the world isn’t worth much unless it translates into good policies. We’re working to marry these segments with the ASP,” Osterholm said.

Osterholm believes this has implications for health not just today but also for decades to come. By 2050, antimicrobial resistance could be a bigger killer worldwide than either heart disease or cancer unless action is taken today to address this evolving crisis today.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.